REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Recent Decisions > 2020 >

Decisions 20th January 2020

At the meeting on the 14th January the following decisions were agreed

 

New Drug Requests

 

 

Approved

 

Gentamicin 0.1% cream (TLS Red)

  • For decolonisation treatment of peritoneal dialysis exit sites as per NBT protocol. 

 

Oralieve Artificial Saliva Spray (TLS Green)

  • Approved as first line option for artificial saliva spray

Famotidine (TLS Amber no SCP)

  • Approved for temporary use instead of ranitidine in specific patients on advice of their secondary care specialist until such time as they are switched back by their specialist. 

Nizatidine (TLS Amber no SCP)

  • Approved for temporary use instead of ranitidine in specific patients on advice of their secondary care specialist until such time as they are switched back by their specialist. 

 

Shared Care Protocols/TLS changes

 

Mycophenolate mofetil , mycophenolate sodium (TLS Amber 1 month)

  • TLS change from Red to Amber 1 month for use in rheumatological conditions, approved in principle pending submission of a SCP.